tiprankstipranks
Pure Bioscience (PURE)
OTHER OTC:PURE

Pure Bioscience (PURE) Income Statement

39 Followers

Pure Bioscience Income Statement

Last quarter (Q1 2024), Pure Bioscience's total revenue was $722.00K, an increase of 75.24% from the same quarter last year. In Q1, Pure Bioscience's net income was $-735.00K. See Pure Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jul 22Jul 21Jul 20Jul 19Jul 18
Total Revenue
$ 2.00M$ 1.85M$ 3.93M$ 6.92M$ 1.91M$ 1.77M
Cost of Revenue
$ 483.00K$ 853.00K$ 1.85M$ 2.90M$ 728.00K$ 763.00K
Gross Profit
$ 1.09M$ 1.00M$ 2.08M$ 4.02M$ 1.18M$ 1.01M
Operating Expense
$ 2.58M$ 4.72M$ 4.39M$ 4.02M$ 6.77M$ 8.05M
Operating Income
$ -1.07M$ -3.72M$ -2.31M$ 4.00K$ -5.59M$ -7.04M
Net Non Operating Interest Income Expense
$ -30.00K$ -6.00K$ -4.00K$ -5.00K$ -6.00K$ -8.00K
Other Income Expense
$ -6.00K$ 60.00K$ 4.00K$ 5.00K$ -959.00K$ -392.00K
Pretax Income
$ -1.10M$ -3.49M$ -2.32M$ 4.00K$ -6.55M$ -7.44M
Tax Provision
-$ 1.65K$ -1.65K---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -1.10M$ -3.49M$ -2.32M$ 4.00K$ -6.55M$ -7.44M
Basic EPS
$ -0.04$ -0.04$ -0.03$ 0.00$ -0.09$ -0.11
Diluted EPS
$ -0.04$ -0.04$ -0.03$ 0.00$ -0.09$ -0.11
Basic Average Shares
$ 445.93M$ 88.84M$ 87.17M$ 82.21M$ 72.88M$ 67.28M
Diluted Average Shares
$ 445.93M$ 88.84M$ 87.17M$ 84.61M$ 72.88M$ 67.28M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 3.06M$ 5.58M$ 6.24M$ 6.91M$ 7.50M$ 8.82M
Net Income From Continuing And Discontinued Operation
$ -3.66M$ -3.49M$ -2.32M$ 4.00K$ -6.55M$ -7.44M
Normalized Income
$ -1.72M$ -2.46M-$ 4.00K$ -5.59M$ -7.03M
Interest Expense
$ 2.00K--$ 5.00K$ 6.00K$ 8.00K
EBIT
$ -1.07M$ -3.48M$ -2.31M$ 9.00K$ -6.55M$ -7.43M
EBITDA
$ -931.00K$ -3.27M$ -2.14M$ 201.00K$ -6.31M$ -7.15M
Currency in USD

Pure Bioscience Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis